Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share (Details) - Schedule of Common Stock Equivalents

v3.24.1.1.u2
Loss Per Share (Details) - Schedule of Common Stock Equivalents - shares
 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 12,373,450 12,615,040
Convertible Notes [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 9,341,825 9,341,825
Options [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 3,031,625 3,232,112
Warrants [Member]    
Schedule of Common Stock Equivalents [Line Items]    
Total common stock equivalents 41,103